AGP Pharmaceuticals: Major
Health Technology
Mkt Cap
52.1B
P/E (TTM)
14.18
EPS
13.34
ROE
24.55%
Div Yield
4.30%
About
AGP Ltd. engages in the import, marketing, export, dealership, distribution, wholesale, and manufacturing of pharmaceuticals and healthcare products. Its products include aminoglycosides, anti epileptics, anti-gout, antifibrinolytic, antiobesity, macrolides, and narcotic analgesic. The company was founded in 1989 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 28.89B | 25.03B | 18.74B | 14.46B | 9.32B | |
| Gross Profit | 16.77B | 14.17B | 9.79B | 7.10B | 4.88B | |
| Net Income | 3.74B | 2.67B | 1.57B | 1.57B | 1.75B | |
| EPS | 13.34 | 9.53 | 5.59 | 5.61 | 6.24 | |
| ROE | 25.87% | 21.49% | 14.24% | 15.52% | 19.53% | |
| ROA | 12.15% | 9.31% | 7.03% | 9.99% | 13.93% | |
| Gross Margin | 58.06% | 56.61% | 52.21% | 49.11% | 52.42% | |
| Net Margin | 12.93% | 10.66% | 8.35% | 10.86% | 18.75% | |
| Current Ratio | 1.01 | 1.08 | 1.16 | 1.30 | 1.62 | |
| DPS | 8.00 | 4.00 | 2.50 | 2.00 | 2.50 | |
| Free Cash Flow | 4.65B | 4.42B | 1.88B | 158.33M | 1.64B |